Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Ethambutol [(S,S')-2,2'-(ethylenediimino)di-1-butanol; EMB], is a first-line drug used to treat tuberculosis. To gain insight into the molecular basis of EMB resistance, we characterized the 10-kb embCAB locus in 16 EMB-resistant and 3 EMB-susceptible genetically distinct Mycobacterium tuberculosis...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Sreevatsan, S, Stockbauer, K E, Pan, X, Kreiswirth, B N, Moghazeh, S L, Jacobs, W R, Telenti, A, Musser, J M
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1997
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163984/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9257740/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.8.1677
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Antzeko izenburuak